医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

MiraMed’s Global Subsidiary MiraMed Philippines Group Completes SOC Type II Examination

2016年01月20日 AM12:20
このエントリーをはてなブックマークに追加


 

JACKSON, Mich.

MiraMed Global Services, Inc. (MiraMed) is pleased to announce that its global subsidiary, MiraMed Philippines Group, LLC – Philippine Branch (MMPG), has completed its Service Organization Controls (SOC) Type II Examination.

The independent SOC examination was conducted by Plante Moran, PLLC a public accounting and consulting firm who evaluated and tested the company’s internal operational controls and processes.

SOC II is a generally accepted auditing standard utilized by service organizations to demonstrate their internal controls and security practices to their clients. By completing the SOC examination, MMPG can now offer third-party verification of its significant control practices and operational procedures.

Conducting a comprehensive SOC examination requires substantial financial and time investments, but MiraMed and MMPG considered the review a mandatory aspect of its continuing commitment to process improvement. “Our dedication to exacting security methods and internal controls has allowed us to consistently offer our clients an unprecedented level of quality and service,” said Tony Mira, President and CEO of parent company, MiraMed Global Services. “The SOC examination signifies that MMPG makes our business processes and the security of our clients’ data top priorities.”

About Plante & Moran

Plante & Moran is one of the nation’s largest certified public accounting and business advisory firms, providing clients with financial, human capital, operations, strategy, technology and family wealth management services. Plante & Moran, headquartered in Southfield, Michigan, has been recognized by a number of organizations, including FORTUNE magazine, as one of the country’s best places to work. For more information please visit www.plantemoran.com.

About MiraMed Philippines:

MiraMed Philippines Group, LLC – Philippine Branch, a subsidiary of MiraMed Global Services, Inc., offers inpatient, outpatient, and physician practice coding solutions. We adhere to Federal, State and client-specific coding guidelines, policies and procedures. We commit to exceed industry standards in accuracy and productivity which will demonstrate a return on your investment.

About MiraMed:

Headquartered in Jackson, Michigan, MiraMed Global Services, Inc. stands as the premier global provider of business process outsourcing solutions to healthcare organizations nationwide. MiraMed partners with hospitals, health networks, physician practices and related industry service organizations to provide a broad portfolio of customizable solutions, uncover and capitalize on hidden financial opportunities, improve productivity and ultimately increase profits. MiraMed has offices in Jackson, Michigan, Chicago, Illinois, Portland, Oregon, Thousand Oaks, California, Dallas, Texas, Boston, Massachusetts, Greenville, South Carolina, Baton Rouge, Louisiana, Chennai, India and Manila, Philippines.

MiraMed pairs healthcare industry experts with world-class processes, infrastructure and technology to deliver meaningful and measurable results. This proprietary model enables sustainable change by delivering a complete, customizable enhanced revenue cycle solutions devised to meet a client’s own unique financial and organizational needs.

If you would like more information, please go to www.miramedgs.com or email info@miramedgs.com.

View source version on businesswire.com: http://www.businesswire.com/news/home/20160119006249/en/

CONTACT

MiraMed Global Services, Inc.
Tony Mira, 517-787-7432
info@miramedgs.com

同じカテゴリーの記事 

  • EMS Kegel Trainer BODYDOCTOR Opens New Era of Health Care Solutions in Global Femcare Market
  • EMSケーゲルトレーナー BODYDOCTOR、Femcareのグローバル市場でK-HEALTH CAREに注目が集まる
  • InnoCare Announces Dosing of First Patient in Clinical Study of the Combination of SHP2 Inhibitor ICP-189 and EGFR Inhibitor Furmonertinib
  • METIS第3相臨床試験で主要評価項目を達成、非小細胞肺がんからの脳転移患者における頭蓋内進行までの期間を統計学的に有意に延長
  • Poxel to Report Its 2023 Annual Results by the End of April 2024